T cell responsiveness to alloantigen is maintained in SCID mice reconstituted with human splenocytes and is inhibited by an anti-CD2 monoclonal antibody.

被引：0
|
作者：
Buckley, M
Brady, D
Schad, V
Latinne, D
Bazin, H
机构：
[1] BIOTRANSPLANT INC,CHARLESTOWN,MA
[2] CATHOLIC UNIV LEUVEN,BRUSSELS,BELGIUM
来源：
FASEB JOURNAL | 1996年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1804 / 1804
页数：1
相关论文
共 50 条
  • [21] Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507
    Zhang, Z
    Zhang, ML
    Ravetch, JV
    Goldman, C
    Waldmann, TA
    BLOOD, 2003, 102 (01) : 284 - 288
  • [22] EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies
    O'Mahony, Deirdre
    Morris, John C.
    Stetler-Stevenson, Maryalice
    Matthews, Helen
    Brown, Margaret R.
    Fleisher, Thomas
    Pittaluga, Stefania
    Raffeld, Mark
    Albert, Paul S.
    Reitsma, Dirk
    Kaucic, Karen
    Hammershaimb, Luz
    Waldmann, Thomas A.
    Janik, John E.
    CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2514 - 2522
  • [23] ANTI-CD2 MONOCLONAL ANTIBODY-INDUCED RECEPTOR CHANGES - DOWN-MODULATION OF CELL-SURFACE CD2
    LIN, JX
    YON, RW
    CHAVIN, KD
    QIN, LH
    WOODWARD, J
    DING, YZ
    YAGITA, H
    BROMBERG, JS
    TRANSPLANTATION, 1995, 59 (08) : 1162 - 1171
  • [24] DIFFERENTIAL IMMUNOMODULATION BY ANTI-CD2 MONOCLONAL-ANTIBODIES OF ANTI-CD3-INDUCED T-CELL ACTIVATION - DEPENDENCE UPON THE INDIVIDUAL ANTI-CD3 MONOCLONAL-ANTIBODY USED FOR ACTIVATION
    STOHL, W
    POSNETT, DN
    CHIORAZZI, N
    CELLULAR IMMUNOLOGY, 1988, 116 (01) : 73 - 85
  • [25] PARTIAL CHARACTERIZATION OF A MINOR T-CELL SUBSET IN HUMAN PERIPHERAL-BLOOD THAT BLOCKS ANTIBODY-PRODUCTION INDUCED BY ANTI-CD2 MONOCLONAL-ANTIBODIES
    TSUNODA, T
    GRAY, JD
    HORWITZ, DA
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A192 - A192
  • [26] INHIBITION BY ANTI-CD2 MONOCLONAL-ANTIBODIES OF ANTI-CD3-INDUCED T-CELL-DEPENDENT B-CELL ACTIVATION
    STOHL, W
    CROW, MK
    CELLULAR IMMUNOLOGY, 1990, 130 (02) : 257 - 270
  • [27] ANTI-CD2 AND ANTI-CD3 INDUCED T-CELL CYTOTOXICITY OF HUMAN INTRAEPITHELIAL AND LAMINA PROPRIA LYMPHOCYTES
    RUTHLEIN, J
    HEINZE, G
    AUER, IO
    GUT, 1992, 33 (12) : 1626 - 1632
  • [28] ANTI-CD4 AND ANTI-CD2 MONOCLONAL-ANTIBODY INFUSIONS IN SUBJECTS WITH MULTIPLE-SCLEROSIS - IMMUNOSUPPRESSIVE EFFECTS AND HUMAN ANTI-MOUSE RESPONSES
    HAFLER, DA
    RITZ, J
    SCHLOSSMAN, SF
    WEINER, HL
    JOURNAL OF IMMUNOLOGY, 1988, 141 (01): : 131 - 138
  • [29] Anti-interleukin 12 antibody prevents experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+T cells.
    Liu, ZJ
    Colpaert, S
    Overbergh, L
    Heremans, H
    Ceuppens, JL
    Geboes, K
    Rutgeerts, PJ
    GASTROENTEROLOGY, 2000, 118 (04) : A576 - A576
  • [30] Radioimmunotherapy of SCID mice bearing human B-cell lymphoma using I-131 labeled anti-CD20 monoclonal antibody
    Oriuchi, N
    Higuchi, T
    Alyafei, S
    Zhang, H
    Nakasone, Y
    Watanabe, N
    Kanda, H
    Hashimoto, M
    Inoue, T
    Endo, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1213 - 1213
12345